Developer docs
API playgroundTry for free, no card

Search company profiles

Cryopets

Full company profile

uuid000f72k

Namestring
Cryopets
Legal namestring
Cryopets, Inc.
Websiteurl
cryopets.com
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Cryopets, Inc. is a privately held, U.S.-based (Boerne/San Antonio, Texas) pet cryopreservation service founded in 2022 by Thiel Fellow Kai Micah Mills. The company applies human-cryopreservation techniques — vitrification with VM-1 and M22 cryoprotective agents, slow liquid-nitrogen cooldown to −196°C, and long-term storage in power-independent cryogenic dewars — to companion animals at the end of their natural lives. Its field-deployable cryo ambulances perform stabilization, cryoprotection, and transport anywhere in the continental US, and the company is constructing a permanent long-term care facility in Boerne alongside a planned American Biostasis Foundation nonprofit, co-built with Tomorrow Bio, CryoDAO, and HydraDAO.

The product offering is structured as three tiered cryopreservation protocols — Standard Preservation (VM-1), Advanced Preservation (M22), and Straight Freeze — augmented by the Ambulance SST (Standby, Stabilization, Transport) field service. Pricing is not yet public and is described as "coming soon," with payments permitted over time until preservation. Customer acquisition is direct-to-consumer via a free website waitlist (capped at 10,000 free spots), supplemented by phone consultation and emergency response lines. The scientific team is led by CSO Chana Phaedra (formerly of Alcor, the Institute for Evidence Based Cryonics, and Advanced Neural Biosciences), with founder-led linkages to CryoDAO and HydraDAO providing research capital and ecosystem alignment.

Revenue is undisclosed and the company has just completed its first commercial preservation (a Siberian Husky named Datsyuk). Backed by approximately $1.5M raised in December 2025 (Prelude, Valyrian, Zee Prime Capital) alongside earlier support from Thiel Fellowship, Gaingels, Novelty Ventures, TruVenturo, Roadrunner Ventures, and others, Cryopets is in a pre-commercial scaling phase: building clinical capacity, formalizing pricing, and constructing the long-term care infrastructure required to deliver on a multi-decade custodianship promise to pet owners.

Short descriptiontext

Cryopets is a U.S. pet cryopreservation service that uses vitrification and custom cryo ambulances to preserve companion animals at end of life, serving pet owners across the continental United States through a waitlist-based direct-to-consumer membership model.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBoerne, United States
HQ citystring
Boerne
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pet cryopreservation services, cryosleep for pets, vitrification procedures, cryogenic storage, pet end-of-life preservation
Industry2 codes
PRIMARYHLAMADAF
Reproductive & Endocrinology Diagnostics (Fertility, Hormones)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Diagnostics (Labs & Imaging)
SECONDARYHSALAFAH
Hot/Cold Therapy Services (Cryotherapy/Ice Baths)
Product category
Pet Cryopreservation Services
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Cryosleep Procedure Services
TypeOne Time License
Description

Cryopets generates revenue through cryosleep procedure services with three tiers: Standard Preservation (VM-1), Advanced Preservation (M22), and Straight Freeze. Pricing can be paid over time up until the preservation. Membership includes access to the cryosleep procedure and long-term care.

cryopets.com
2Long-term Storage
TypeOne Time License
Description

One-time storage payment for indefinite cryogenic preservation. Families pay for storage one time, not as ongoing monthly or annual bill. This one-time storage fund is managed conservatively to stay ahead of inflation over time.

cryopets.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Infrastructure, Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales
Pricing details3 tiers
1Standard Preservation using VM-1 cryoprotectant
ModelOtherBilling cadencePay-as-you-go
Notes

Pricing coming soon. Balances quality and cost for most families. Includes slow cooldown, long-term storage (Liquid Nitrogen), VM-1 cryoprotective agent, CT scan for quality assessment, and Ambulance SST.

cryopets.com
2Advanced Preservation using M22 cryoprotectant
ModelOtherBilling cadencePay-as-you-go
Notes

Pricing coming soon. Most advanced protocol designed for best possible preservation. Includes slow cooldown, long-term storage (Liquid Nitrogen), research-grade M22 cryoprotective agent, CT scan for quality assessment, and Ambulance SST.

cryopets.com
3Straight Freeze (traditional freezing without cryoprotectants)
ModelOtherBilling cadencePay-as-you-go
Notes

Pricing coming soon. Traditional freezing without cryoprotectants - most commonly used when other options are not possible. Lower-cost option for basic preservation. Includes slow cooldown and long-term storage. Shipping required (Ambulance SST not included).

cryopets.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Cryopets provides pet cryopreservation (cryosleep) services through three procedure tiers — Standard Preservation (VM-1), Advanced Preservation (M22), and Straight Freeze — combined with mobile cryo ambulance standby, stabilization, and transport, slow liquid nitrogen cooldown, and indefinite cryogenic dewar storage at -196°C. The service is delivered directly to pet owners, with procedures performed in the field by trained surgeons near the pet's veterinary clinic.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Cryopets offers a tiered cryopreservation service for pets, comprising three procedure options—Standard Preservation (VM-1), Advanced Preservation (M22), and Straight Freeze—alongside an Ambulance SST (Standby, Stabilization and Transport) service. The service portfolio follows a five-stage process: stabilization using cryo ambulances, transport to the facility, slow cooldown in specialized chambers, long-term cryosleep storage in liquid nitrogen dewars, and future revival when medical technology permits. The higher-tier protocols differ in cryoprotectant quality, inclusion of CT scan assessment, and ambulance coverage.

Product and service4 records
1Standard Preservation (VM-1)
CategoryPet cryopreservation procedure
Description

Cryopets' standard cryopreservation protocol using VM-1 cryoprotectant for pet owners, balancing quality and cost. Includes slow cooldown, long-term liquid nitrogen storage, CT scan for quality assessment, and Ambulance SST. Designed for most families seeking a balance of quality and value.

2Advanced Preservation (M22)
CategoryPet cryopreservation procedure
Description

Cryopets' most advanced cryopreservation protocol using the research-grade M22 cryoprotectant, which has enabled whole mammalian organ recovery. Includes slow cooldown, liquid nitrogen storage, CT scan quality assessment, and Ambulance SST. Intended for pet owners who want the best possible preservation quality.

3Straight Freeze
CategoryPet cryopreservation procedure
Description

Traditional freezing preservation without cryoprotectants, used when other options are not possible. Lower-cost option with greater risk of cellular damage from ice formation. Includes slow cooldown and long-term liquid nitrogen storage but does not include cryoprotective agents, CT scan quality assessment, or Ambulance SST.

4Ambulance SST (Standby, Stabilization and Transport)
CategoryField cryopreservation service
Description

Field cryopreservation service where Cryopets drives custom-built cryo ambulances to pet owners anywhere in the continental U.S., performs the full cryoprotection procedure near the pet's veterinary clinic, and transports the pet to the long-term care facility. Time-critical service for optimal preservation from the first moment.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1American Biostasis Foundation (ABF)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

ABF is the upcoming nonprofit and planned home of Cryopets' permanent long-term patient care facility. It is purpose-built to operate secure, indefinite patient storage alongside cryopreservation research and public education. ABF is being built in partnership with Cryopets, Tomorrow Bio, CryoDAO, and HydraDAO to align clinical providers, research capital, and governance for responsible scaling.

cryopets.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Leading biostasis provider partnering with Cryopets to build the American Biostasis Foundation. Tomorrow Bio is part of the coalition supporting ABF's nonprofit model for transparent custodianship for people and pets in cryostorage.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

Berlin-based human cryopreservation provider operating field standby/transport across Europe. Directly comparable business model (ambulance SST, vitrification, long-term storage), with Cryopets explicitly partnering with Tomorrow Bio via the American Biostasis Foundation coalition.

TypeBroad incumbent
Description

Long-established (1972) human cryopreservation organization with full-body and neurocryopreservation services. Comparable vitrification protocols (M22 is associated with Alcor-adjacent research) and Cryopets' CSO is a former Alcor researcher, making Alcor the most direct scientific lineage peer.

TypeBroad incumbent
Description

Michigan-based human cryopreservation nonprofit operating since 1976. Comparable long-term liquid nitrogen storage model and member-funded custody structure, though without the field-deployment ambulance model that differentiates Cryopets.

TypeEmerging player
Description

Pet stem cell banking company enabling owners to preserve their pet's living cells for future regenerative use. Closest commercial analog to Cryopets' value proposition (preserving pet biology for future medical use), though focused on cellular rather than whole-body preservation.

TypeEmerging player
Description

Veterinary regenerative medicine company offering pet stem cell banking and regenerative therapies. Addresses the same 'preserve pet biology for future treatment' pain point as Cryopets, with a more validated near-term delivery model but no whole-body preservation.

6Oregon Cryonics
TypeBroad incumbent
Description

Standby, stabilization, and transport provider for human cryopreservation cases across the western US. Directly comparable field-deployment logistics role to Cryopets' ambulance SST, but as a B2B service provider rather than a consumer-facing brand.

7Southern Cryonics
TypeRegional player
Description

Australia's first cryopreservation organization, offering full-body and neurocryopreservation services. Operates the same full-stack cryopreservation + long-term storage model as Cryopets but in a different geographic market.

8Yinfeng Cryobiology
TypeBroad incumbent
Description

China-based cryobiology company offering cryopreservation services (notably including what they describe as the first human cryopreservation in China). Comparable full-stack cryopreservation model with state-affiliated research backing, addressing a different geographic and regulatory environment.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cryopets

Pet Cryopreservation Servicescryopets.com

Cryopets is a U.S. pet cryopreservation service that uses vitrification and custom cryo ambulances to preserve companion animals at end of life, serving pet owners across the continental United States through a waitlist-based direct-to-consumer membership model.

What Cryopets does

Cryopets, Inc. is a privately held, U.S.-based (Boerne/San Antonio, Texas) pet cryopreservation service founded in 2022 by Thiel Fellow Kai Micah Mills. The company applies human-cryopreservation techniques — vitrification with VM-1 and M22 cryoprotective agents, slow liquid-nitrogen cooldown to −196°C, and long-term storage in power-independent cryogenic dewars — to companion animals at the end of their natural lives. Its field-deployable cryo ambulances perform stabilization, cryoprotection, and transport anywhere in the continental US, and the company is constructing a permanent long-term care facility in Boerne alongside a planned American Biostasis Foundation nonprofit, co-built with Tomorrow Bio, CryoDAO, and HydraDAO.

The product offering is structured as three tiered cryopreservation protocols — Standard Preservation (VM-1), Advanced Preservation (M22), and Straight Freeze — augmented by the Ambulance SST (Standby, Stabilization, Transport) field service. Pricing is not yet public and is described as "coming soon," with payments permitted over time until preservation. Customer acquisition is direct-to-consumer via a free website waitlist (capped at 10,000 free spots), supplemented by phone consultation and emergency response lines. The scientific team is led by CSO Chana Phaedra (formerly of Alcor, the Institute for Evidence Based Cryonics, and Advanced Neural Biosciences), with founder-led linkages to CryoDAO and HydraDAO providing research capital and ecosystem alignment.

Revenue is undisclosed and the company has just completed its first commercial preservation (a Siberian Husky named Datsyuk). Backed by approximately $1.5M raised in December 2025 (Prelude, Valyrian, Zee Prime Capital) alongside earlier support from Thiel Fellowship, Gaingels, Novelty Ventures, TruVenturo, Roadrunner Ventures, and others, Cryopets is in a pre-commercial scaling phase: building clinical capacity, formalizing pricing, and constructing the long-term care infrastructure required to deliver on a multi-decade custodianship promise to pet owners.

Cryopets firmographics

Firmographics
Name
Cryopets
Legal name
Cryopets, Inc.
Website
https://cryopets.com
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
1–10 employees
Short description
Cryopets is a U.S. pet cryopreservation service that uses vitrification and custom cryo ambulances to preserve companion animals at end of life, serving pet owners across the continental United States through a waitlist-based direct-to-consumer membership model.
Ownership category
akta.pro rank

Cryopets industry classification

Industry
Product category
Pet Cryopreservation Services
akta.pro industry
PRIMARYHLAMADAF
Reproductive & Endocrinology Diagnostics (Fertility, Hormones)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Diagnostics (Labs & Imaging)
SECONDARYHSALAFAH
Hot/Cold Therapy Services (Cryotherapy/Ice Baths)

Keywords

  • Pet cryopreservation services
  • Cryosleep for pets
  • Vitrification procedures
  • Cryogenic storage
  • Pet end-of-life preservation

Where Cryopets is headquartered

Location

Headquarters

HQ city
Boerne
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Cryopets business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Infrastructure, Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales

Revenue model

  1. Cryosleep Procedure Services: Cryopets generates revenue through cryosleep procedure services with three tiers: Standard Preservation (VM-1), Advanced Preservation (M22), and Straight Freeze. Pricing can be paid over time up until the preservation. Membership includes access to the cryosleep procedure and long-term care.
  2. Long-term Storage: One-time storage payment for indefinite cryogenic preservation. Families pay for storage one time, not as ongoing monthly or annual bill. This one-time storage fund is managed conservatively to stay ahead of inflation over time.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goStandard Preservation using VM-1 cryoprotectant
OtherPay-as-you-goAdvanced Preservation using M22 cryoprotectant
OtherPay-as-you-goStraight Freeze (traditional freezing without cryoprotectants)

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Cryopets product offering

Product offering

Core offering

Cryopets provides pet cryopreservation (cryosleep) services through three procedure tiers — Standard Preservation (VM-1), Advanced Preservation (M22), and Straight Freeze — combined with mobile cryo ambulance standby, stabilization, and transport, slow liquid nitrogen cooldown, and indefinite cryogenic dewar storage at -196°C. The service is delivered directly to pet owners, with procedures performed in the field by trained surgeons near the pet's veterinary clinic.

Product overview

Cryopets offers a tiered cryopreservation service for pets, comprising three procedure options—Standard Preservation (VM-1), Advanced Preservation (M22), and Straight Freeze—alongside an Ambulance SST (Standby, Stabilization and Transport) service. The service portfolio follows a five-stage process: stabilization using cryo ambulances, transport to the facility, slow cooldown in specialized chambers, long-term cryosleep storage in liquid nitrogen dewars, and future revival when medical technology permits. The higher-tier protocols differ in cryoprotectant quality, inclusion of CT scan assessment, and ambulance coverage.

Differentiator

Problem solved

Functional benefit

Products and services

  • Standard Preservation (VM-1) Cryopets' standard cryopreservation protocol using VM-1 cryoprotectant for pet owners, balancing quality and cost. Includes slow cooldown, long-term liquid nitrogen storage, CT scan for quality assessment, and Ambulance SST. Designed for most families seeking a balance of quality and value.
  • Advanced Preservation (M22) Cryopets' most advanced cryopreservation protocol using the research-grade M22 cryoprotectant, which has enabled whole mammalian organ recovery. Includes slow cooldown, liquid nitrogen storage, CT scan quality assessment, and Ambulance SST. Intended for pet owners who want the best possible preservation quality.
  • Straight Freeze Traditional freezing preservation without cryoprotectants, used when other options are not possible. Lower-cost option with greater risk of cellular damage from ice formation. Includes slow cooldown and long-term liquid nitrogen storage but does not include cryoprotective agents, CT scan quality assessment, or Ambulance SST.
  • Ambulance SST (Standby, Stabilization and Transport) Field cryopreservation service where Cryopets drives custom-built cryo ambulances to pet owners anywhere in the continental U.S., performs the full cryoprotection procedure near the pet's veterinary clinic, and transports the pet to the long-term care facility. Time-critical service for optimal preservation from the first moment.

Companies that use Cryopets

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Cryopets technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Cryopets partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • American Biostasis Foundation (ABF)coreStrategic or Co-development PartnerABF is the upcoming nonprofit and planned home of Cryopets' permanent long-term patient care facility. It is purpose-built to operate secure, indefinite patient storage alongside cryopreservation research and public education. ABF is being built in partnership with Cryopets, Tomorrow Bio, CryoDAO, and HydraDAO to align clinical providers, research capital, and governance for responsible scaling.
  • Tomorrow BiocoreStrategic or Co-development PartnerLeading biostasis provider partnering with Cryopets to build the American Biostasis Foundation. Tomorrow Bio is part of the coalition supporting ABF's nonprofit model for transparent custodianship for people and pets in cryostorage.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Cryopets competitors and assessment

Company assessment

Direct peers

  • Tomorrow Bio: Berlin-based human cryopreservation provider operating field standby/transport across Europe. Directly comparable business model (ambulance SST, vitrification, long-term storage), with Cryopets explicitly partnering with Tomorrow Bio via the American Biostasis Foundation coalition.

Broad incumbents

  • Alcor Life Extension Foundation: Long-established (1972) human cryopreservation organization with full-body and neurocryopreservation services. Comparable vitrification protocols (M22 is associated with Alcor-adjacent research) and Cryopets' CSO is a former Alcor researcher, making Alcor the most direct scientific lineage peer.
  • Cryonics Institute: Michigan-based human cryopreservation nonprofit operating since 1976. Comparable long-term liquid nitrogen storage model and member-funded custody structure, though without the field-deployment ambulance model that differentiates Cryopets.
  • Oregon Cryonics: Standby, stabilization, and transport provider for human cryopreservation cases across the western US. Directly comparable field-deployment logistics role to Cryopets' ambulance SST, but as a B2B service provider rather than a consumer-facing brand.
  • Yinfeng Cryobiology: China-based cryobiology company offering cryopreservation services (notably including what they describe as the first human cryopreservation in China). Comparable full-stack cryopreservation model with state-affiliated research backing, addressing a different geographic and regulatory environment.

Emerging players

  • Acorn Biolabs: Pet stem cell banking company enabling owners to preserve their pet's living cells for future regenerative use. Closest commercial analog to Cryopets' value proposition (preserving pet biology for future medical use), though focused on cellular rather than whole-body preservation.
  • Gallant (formerly Forever Labs): Veterinary regenerative medicine company offering pet stem cell banking and regenerative therapies. Addresses the same 'preserve pet biology for future treatment' pain point as Cryopets, with a more validated near-term delivery model but no whole-body preservation.

Regional players

  • Southern Cryonics: Australia's first cryopreservation organization, offering full-body and neurocryopreservation services. Operates the same full-stack cryopreservation + long-term storage model as Cryopets but in a different geographic market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Cryopets social profiles

Digital presence

Cryopets financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cryopets leadership team

Management profile

Number of profiles

Profiles6 records

Cryopets funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cryopets M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cryopets

What does Cryopets do?

Cryopets provides pet cryopreservation (cryosleep) services through three procedure tiers — Standard Preservation (VM-1), Advanced Preservation (M22), and Straight Freeze — combined with mobile cryo ambulance standby, stabilization, and transport, slow liquid nitrogen cooldown, and indefinite cryogenic dewar storage at -196°C. The service is delivered directly to pet owners, with procedures performed in the field by trained surgeons near the pet's veterinary clinic.

Is Cryopets a public or private company?

Cryopets is a private company. It is classified as venture growth investor backed and is currently operating.

When was Cryopets founded?

Cryopets was founded in 2022. It employs 1 to 10 people.

Where is Cryopets based?

Cryopets is headquartered in Boerne, United States, in the North America region.

How does Cryopets make money?

Two revenue lines are on record. Cryosleep Procedure Services are the primary driver. The others are long-term Storage.

Who are Cryopets's main competitors?

Tomorrow Bio is listed as a direct peer. Broad incumbents are Alcor Life Extension Foundation, Cryonics Institute, Oregon Cryonics and Yinfeng Cryobiology. Emerging players are Acorn Biolabs and Gallant (formerly Forever Labs). Southern Cryonics is listed as a regional player.

Does Cryopets have an API?

No public API is recorded for Cryopets.

What industry is Cryopets in?

Cryopets's product category is Pet Cryopreservation Services. Its primary akta.pro industry code is HLAMADAF, Reproductive & Endocrinology Diagnostics (Fertility, Hormones), with a secondary code of HSALAFAH, Hot/Cold Therapy Services (Cryotherapy/Ice Baths).

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business InsiderPet owners will freeze their dying animals to one day bring them back to life. Billionaire Peter Thiel is backing the technology to make it happen.Kai Micah Mills, a Thiel Fellow, founded Cryopets to freeze pets after death for possible future revival. The startup has a waitlist of about 500 animals and plans to hire a veterinarian and research organ-warming methods. Mills hopes to expand to human preservation later.BenzingaPet Owners And Billionaires Invest In Cryonics To Resurrect Beloved AnimalsKai Micah Mills, a 24-year-old entrepreneur from Utah, founded Cryopets, a startup that preserves deceased pets at deep-freeze temperatures in liquid nitrogen, aiming to revive them when technology advances. Mills received a $100,000 Thiel Fellowship from billionaire investor Peter Thiel, and the company currently has about 500 pets on its waitlist including dogs, cats, rabbits, hamsters and one monkey. The longevity sector received $5.2 billion in financing last year, and Mills hopes to expand to human preservation as the science matures and pet owners become more open to the idea.BenzingaPeter Thiel Wants To Conquer Death With Cryogenic Preservation: 'We Haven't Even Tried'PayPal co-founder Peter Thiel discussed his interest in conquering death through cryogenic preservation on the 'Honestly with Bari Weiss' podcast, stating 'We haven't even tried' as his rationale for pursuing the technology. Thiel revealed he has personally signed up for cryogenic preservation and acknowledged he doesn't necessarily expect it to work, framing it as something worth attempting. The billionaire has invested millions of dollars in life extension research and recently invested in Cryopets, a service offering pet cryopreservation.